# MEPRON
> **NDA020500** · New Drug Application · Sponsor: GLAXOSMITHKLINE LLC · Approved 1995-02-08
## Drug
- **FDA Application Number:** NDA020500
- **Application type:** New Drug Application
- **Brand name:** MEPRON
- **Generic name:** ATOVAQUONE
- **Active ingredients:** ATOVAQUONE
- **Dosage form:** SUSPENSION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** GLAXOSMITHKLINE LLC
- **Manufacturer:** GlaxoSmithKline LLC
- **First approval:** 1995-02-08
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020500)
---
*AI Analytics · CC0 1.0*